Hypertension, Statin Use Increased for Individuals Using TAF for PrEP
THURSDAY, Sept. 14, 2023 (HealthDay News) — For individuals taking preexposure prophylaxis (PrEP) for preventing HIV infection, tenofovir alafenamide fumarate (TAF) use is associated with higher incident hypertension and statin initiation compared wi…
Learn MoreInterventions Can Increase Adjuvant Endocrine Treatment Adherence
THURSDAY, Sept. 14, 2023 (HealthDay News) — Lowering medication costs and some psychosocial and reminder interventions show the most promise for promoting adjuvant endocrine therapy (AET) adherence in breast cancer survivors, according to a review pu…
Learn MoreInterventions Can Increase Adjuvant Endocrine Treatment Adherence
THURSDAY, Sept. 14, 2023 (HealthDay News) — Lowering medication costs and some psychosocial and reminder interventions show the most promise for promoting adjuvant endocrine therapy (AET) adherence in breast cancer survivors, according to a review pu…
Learn MoreRisk for Dementia Reduced in Association With Antihypertensive Use
WEDNESDAY, Sept. 13, 2023 (HealthDay News) — Antihypertensive use is associated with a reduced risk for dementia compared with untreated hypertension, according to research published online Sept. 12 in JAMA Network Open.Matthew J. Lennon, M.D., from …
Learn MoreAntipsychotic Use Increased for Seniors With Alzheimer, Related Dementias
TUESDAY, Sept. 12, 2023 (HealthDay News) — Antipsychotics are more often used by older adults receiving home health care (HHC) services with Alzheimer disease and related dementias (ADRD) versus those without ADRD, and their use is associated with wo…
Learn MoreGefapixant Leads to Modest Improvements in Cough
MONDAY, Sept. 11, 2023 (HealthDay News) — For adults with refractory or unexplained chronic cough, gefapixant leads to modest improvement in cough frequency, severity, and quality of life, according to a review published online Sept. 11 in the Journa…
Learn MoreAdverse Association Identified for Calcium Channel Blocker Use, Glaucoma
FRIDAY, Sept. 8, 2023 (HealthDay News) — There is an adverse association between calcium channel blocker (CCB) use and glaucoma, according to a study published online Sept. 7 in JAMA Ophthalmology.Alan Kastner, M.D., from Moorfields Eye Hospital Nati…
Learn MoreEn un pequeño estudio, Ozempic ayudó a personas con diabetes tipo 1 a dejar los tratamientos con insulina
JUEVES, 7 de septiembre de 2023 (HealthDay News) — El exitoso medicamento Ozempic se ha convertido en un nombre familiar por su capacidad para impulsar la pérdida de peso. Ahora, un estudio preliminar sugiere una posibilidad intrigante: el medicament…
Learn MoreIn Small Study, Ozempic Helped People With Type 1 Diabetes Quit Insulin Treatments
THURSDAY, Sept. 7, 2023 (HealthDay News) — The blockbuster drug Ozempic has become a household name for its ability to spur weight loss. Now an early study hints at an intriguing possibility: The drug might allow people newly diagnosed with type 1 di…
Learn MoreIn Small Study, Ozempic Helped People With Type 1 Diabetes Quit Insulin Treatments
THURSDAY, Sept. 7, 2023 (HealthDay News) — The blockbuster drug Ozempic has become a household name for its ability to spur weight loss. Now an early study hints at an intriguing possibility: The drug might allow people newly diagnosed with type 1 di…
Learn More